HK Stock Market Move | Weichai Power (02338) rises more than 5%, generating recognition from OpenAI's large data center. Goldman Sachs is optimistic about the company's valuation reassessment.
Weichai Power (02338) rose more than 5%, as of the time of writing, it increased by 5.41%, to 33.54 Hong Kong dollars, with a turnover of 5.84 billion Hong Kong dollars.
Weichai Power (02338) rose more than 5%, and as of the time of publication, it was up 5.41% to HK$33.54, with a turnover of HK$5.84 billion.
On the news front, Goldman Sachs released a research report stating that OpenAI's US license documents for the "Stargate" in the Texas data center show that they are using emergency generators from Weichai Power's wholly-owned subsidiary "Boduan," marking a significant milestone for Boduan as it gains recognition from large data center enterprises. This breakthrough once again confirms Goldman Sachs' positive outlook on Weichai, with expectations of significant growth opportunities in the under-supplied AIDC power generation equipment industry, and potential for a valuation reassessment after a major shift in investment trends.
Goldman Sachs also notes that in March, there will be two major catalysts for Weichai, including the group's plan to announce its full-year performance for last year on March 26, with management expected to provide more guidance on the long-term outlook for the power generation business; and its US core partner Generac's planned investor day for 2026 on March 25, where more details about its data center strategy are expected to be discussed.
Related Articles
.png)
UBS: Raises WH Group (00288) target price to HK$11, visibility of profit and shareholder returns improvement.

CMSC: North America initiates photovoltaic production expansion, domestic benefit emphasizes the importance of auxiliary materials in the supply chain.

Splurge nearly 500 million US dollars, Pfizer Inc. (PFE.US) collaborates with a Chinese biotech company, increasing investment in the weight loss drug market in China.
UBS: Raises WH Group (00288) target price to HK$11, visibility of profit and shareholder returns improvement.
.png)
CMSC: North America initiates photovoltaic production expansion, domestic benefit emphasizes the importance of auxiliary materials in the supply chain.

Splurge nearly 500 million US dollars, Pfizer Inc. (PFE.US) collaborates with a Chinese biotech company, increasing investment in the weight loss drug market in China.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


